Publications by authors named "Adam C Lane"

Claim this Profile
S
Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial.
Rosa M Nieves, Teresa Latham, Nicolle Marte, Melissa Berges, Luisanna M Sánchez, Adam C Lane

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyurea for Children and Adults with Hemoglobin SC Disease.
Yvonne A Dei-Adomakoh, Catherine I Segbefia, Teresa S Latham, Adam C Lane, Klenam Dzefi-Tettey

NEJM Evid· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa.
Catherine I Segbefia, Luke R Smart, Susan E Stuber, Kwesi N Amissah-Arthur, Klenam Dzefi-Tettey, Adam C Lane

Br J Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC disease.
Luke R Smart, Catherine I Segbefia, Teresa S Latham, Susan E Stuber, Kwesi N Amissah-Arthur, Adam C Lane

Trials· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial.
Emmanuela E Ambrose, Teresa S Latham, Primrose Songoro, Mwesige Charles, Adam C Lane

Lancet Haematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis